Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
bilador 20 mg tablete
menarini international o.l.s.a. - bilastin - tableta - bilastin 20 mg / 1 tableta - bilastin
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
bilador 20 mg tablete
menarini international o.l.s.a. - bilastin - tableta - bilastin 20 mg / 1 tableta - bilastin
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
bilador 20 mg tablete
menarini international o.l.s.a. - bilastin - tableta - bilastin 20 mg / 1 tableta - bilastin
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
bilador 20 mg tablete
menarini international o.l.s.a. - bilastin - tableta - bilastin 20 mg / 1 tableta - bilastin
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
bilador 10 mg orodisperzibilne tablete
menarini international o.l.s.a. - bilastin - orodisperzibilna tableta - bilastin 10 mg / 1 tableta - bilastin
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
bilador 20 mg tablete
menarini international o.l.s.a. - bilastin - tableta - bilastin 20 mg / 1 tableta - bilastin
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
bilador 10 mg orodisperzibilne tablete
menarini international o.l.s.a. - bilastin - orodisperzibilna tableta - bilastin 10 mg / 1 tableta - bilastin
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
bilador 2,5 mg/ml peroralna raztopina
menarini international o.l.s.a. - bilastin - peroralna raztopina - bilastin 2,5 mg / 1 ml - bilastin
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - predkroglomerna limfoblastna levkemija limfoma - antineoplastična sredstva - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastiki - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.